Sammanfattning

Purpose: Urine proteomics is emerging as a powerful tool for biomarker discovery. The purpose of this study is the development of a well-characterized "real life" sample that can be used as reference standard in urine clinical proteomics studies.Experimental design: We report on the generation of male and female urine samples that are extensively characterized by different platforms and methods (CE-MS, LC-MS, LC-MS/MS, 1-D gel analysis in combination with nano-LC MS/MS (using LTQ-FT ultra), and 2-DE-MS) for their proteome and peptidome. In several cases analysis involved a definition of the actual biochemical entities, i.e. proteins/peptides associated with molecular mass and detected PTMs and the relative abundance of these compounds.Results: The combination of different technologies allowed coverage of a wide mass range revealing the advantages and complementarities of the different technologies. Application of these samples in "inter-laboratory" and "inter-platform" data comparison is also demonstrated.Conclusions and clinical relevance: These well-characterized urine samples are freely available upon request to enable data comparison especially in the context of biomarker discovery and validation studies. It is also expected that they will provide the basis for the comprehensive characterization of the urinary proteome.

Nyckelord

Clinical proteomics; Proteome; Standard; Urine

Publicerad i

PROTEOMICS - Clinical Applications
2010, Volym: 4, nummer: 4, sidor: 464–478

SLU författare

• Norling, Martin

  • Institutionen för husdjurens biovetenskaper, Sveriges lantbruksuniversitet
    

• Bongcam Rudloff, Erik

  • Institutionen för husdjurens biovetenskaper, Sveriges lantbruksuniversitet
    

UKÄ forskningsämne

Bioinformatik (beräkningsbiologi)


Publikationens identifierare

DOI: https://doi.org/10.1002/prca.200900189

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/32923